Profile data is unavailable for this security.
About the company
Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, mainly in dermatology. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, and Vaniqa. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. It delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. It also has the Natroba operations and global product rights to Natroba and its authorized generic Spinosad, a topical treatment for both head lice and scabies.
- Revenue in CAD (TTM)37.03m
- Net income in CAD22.19m
- Incorporated2020
- Employees9.00
- LocationCipher Pharmaceuticals Inc5750 Explorer Drive,, Suite 404MISSISSAUGA L4W 0A9CanadaCAN
- Phone+1 (905) 602-5840
- Websitehttps://www.cipherpharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eastwood Bio-Medical Canada Inc | 653.54k | -484.16k | 68.89m | -- | -- | -- | -- | 105.40 | -0.007 | -0.007 | 0.0095 | -0.0166 | 1.60 | -- | 21.00 | -- | -118.87 | -52.23 | -- | -140.29 | 62.28 | 52.09 | -74.08 | -52.90 | -- | -63.73 | -- | -- | -33.22 | 3.13 | -264.69 | -- | -- | -- |
| Medicus Pharma Ltd | 0.00 | -16.42m | 70.40m | -- | -- | 7.80 | -- | -- | -3.56 | -3.56 | 0.00 | 0.8324 | 0.00 | -- | -- | -- | -267.24 | -652.37 | -371.17 | -- | -- | -- | -- | -- | -- | -20.26 | 0.0549 | -- | -- | -- | -300.86 | -- | -- | -- |
| Theratechnologies Inc | 118.01m | -4.42m | 79.55m | 103.00 | -- | -- | -- | 0.6741 | -0.1293 | -0.1293 | 2.61 | -0.599 | 1.33 | 3.06 | 8.88 | 1,145,715.00 | -5.00 | -26.32 | -- | -55.43 | 76.97 | 65.90 | -3.75 | -38.26 | 0.9691 | 0.9862 | 1.52 | -- | 2.13 | 12.58 | 49.28 | -- | -37.83 | -- |
| Arch Biopartners Inc | 1.38m | -2.57m | 129.30m | -- | -- | -- | -- | 93.45 | -0.0409 | -0.0409 | 0.0221 | -0.1021 | 0.9363 | -- | 1.88 | -- | -174.05 | -214.82 | -- | -- | -- | -- | -185.89 | -180.45 | -- | -3.57 | -- | -- | 105.63 | -- | -136.30 | -- | -- | -- |
| Biosyent Inc | 33.82m | 7.15m | 130.95m | 0.00 | 18.54 | 3.63 | 17.18 | 3.87 | 0.5988 | 0.5988 | 2.83 | 3.06 | 0.8352 | 1.34 | 7.74 | -- | 17.66 | 14.77 | 20.16 | 16.92 | 79.77 | 79.74 | 21.14 | 19.99 | 4.90 | -- | 0.0309 | 9.26 | 13.12 | 7.97 | 18.35 | 2.52 | -2.67 | -- |
| Spectral Medical Inc | 2.01m | -25.08m | 152.72m | 29.00 | -- | -- | -- | 76.13 | -0.0895 | -0.0896 | 0.0072 | -0.1106 | 0.2369 | 3.88 | 3.80 | 69,172.41 | -296.18 | -109.65 | -- | -175.35 | 39.78 | 63.74 | -1,250.20 | -445.72 | 0.2057 | -1.22 | -- | -- | -4.14 | -16.08 | -104.12 | -- | 31.53 | -- |
| Cipher Pharmaceuticals Inc | 37.03m | 22.19m | 325.23m | 9.00 | 14.41 | 2.35 | 12.47 | 8.78 | 0.882 | 0.882 | 1.48 | 5.41 | 0.2166 | 1.30 | 2.66 | 4,114,980.00 | 12.98 | 21.53 | 14.60 | 27.40 | 80.78 | 83.58 | 59.92 | 57.31 | 1.64 | -- | 0.2919 | 0.00 | 2.36 | -1.44 | -23.48 | 76.18 | -53.51 | -- |
| Aurora Cannabis Inc | 296.39m | -29.03m | 349.02m | 1.07k | -- | 0.6424 | -- | 1.18 | -0.6063 | -0.8749 | 5.77 | 9.90 | 0.3643 | 1.69 | 7.42 | 276,222.80 | -3.94 | -- | -4.87 | -- | -0.0165 | -- | -10.81 | -- | 1.88 | -- | 0.1476 | -- | -- | -- | -- | -- | -- | -- |
| Knight Therapeutics Inc | 348.64m | -30.73m | 520.03m | 725.00 | -- | 0.672 | 26.17 | 1.49 | -0.2979 | -0.2979 | 3.42 | 7.66 | 0.3533 | 1.59 | 4.02 | 480,878.60 | -3.11 | 0.3477 | -3.53 | 0.4156 | 48.26 | 46.28 | -8.81 | 1.69 | 2.39 | 0.2385 | 0.07 | 0.00 | 11.80 | 92.24 | 43.68 | -- | 20.79 | -- |
| Canopy Growth Corp | 280.50m | -585.69m | 663.09m | 1.03k | -- | 1.02 | -- | 2.36 | -6.98 | -6.73 | 3.32 | 5.43 | 0.1934 | 2.17 | 6.16 | 272,590.90 | -40.38 | -26.08 | -48.35 | -28.67 | 31.47 | 2.59 | -208.81 | -333.29 | 1.07 | -0.2973 | 0.5462 | -- | -10.83 | 5.59 | 84.29 | -- | -64.60 | -- |
| Cronos Group Inc | 155.68m | -66.57m | 1.16bn | 626.00 | -- | 0.7652 | -- | 7.44 | -0.175 | -0.1745 | 0.4068 | 3.96 | 0.0953 | 2.28 | 6.14 | -- | -4.20 | 6.43 | -4.43 | 7.11 | 14.66 | -10.54 | -44.12 | 147.07 | 23.05 | -- | 0.00 | -- | 0.5672 | 48.40 | 54.99 | -- | -50.99 | -- |
